Streetbeat News

Regulatory

LYRA

Trading for LYRA was halted at 8:55:00 a.m. ET due to pending news.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 12:55 pm

PTCT

The European Commission has requested the Committee for Medicinal Products for Human Use (CHMP) to review its January opinion on the renewal of the marketing authorization for Translarna.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 12:46 pm

PALI

Palisade Bio's PALI-2108 shows promising preclinical results in mouse models for Ulcerative Colitis, demonstrating safety, efficacy, and local bioactivation. The company plans to start Phase 1 human trials by the end of the year.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 12:41 pm

ETHUSD

FDLRX

Fidelity has filed an amended S-1 application with the SEC for a spot Ether ETF, which could mark a significant milestone in the mainstream adoption of Ethereum. Bloomberg analysts estimate a 75% chance of approval, which could have a profound impact on the cryptocurrency market and set a precedent for other asset managers.

Portfolio Pulse from Murtuza Merchant

May 21, 2024 | 12:39 pm

GRI

GRI Bio presented preclinical data on its NKT cell modulators for Systemic Lupus Erythematosus at the 14th International Congress on Autoimmunity. The data is promising and comparable to OFEV® (nintedanib), a leading tyrosine kinase inhibitor. GRI Bio plans to file an IND for GRI-0803 in Q3 2024, with topline data expected in Q4 2024.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 12:37 pm

LHX

SIDU

The Department of Defense (DoD) has extended the Mentor-Protégé Program between Sidus Space, Inc. (NASDAQ:SIDU) and L3Harris Technologies (NYSE:LHX) for an additional year. This program aims to foster partnerships between established defense contractors and smaller, emerging businesses to help them expand in the defense industry.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 12:36 pm

CBOE

NDAQ

The SEC has requested Nasdaq and CBOE to make adjustments to their filings for spot Ether ETFs. This move indicates ongoing regulatory scrutiny and potential delays in the approval process for these financial products.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 12:31 pm

VRNOF

The New Jersey cannabis market, particularly the pre-roll segment, has seen significant growth, with sales reaching $25.5 million in the last quarter of 2023. Verano Holdings Corp (OTC:VRNOF) leads the market with a 21% share. The market is projected to grow further, despite regulatory challenges.

Portfolio Pulse from Abbey Higginbotham

May 21, 2024 | 12:21 pm

MA

V

Visa Inc. (NYSE:V) and Mastercard Inc. (NYSE:MA) are under scrutiny by the UK's Payment Systems Regulator (PSR) for increasing fees on retailers without corresponding service improvements. The PSR's provisional findings indicate a lack of competition in the market, leading to significant fee hikes over the past five years. The PSR has suggested several remedies for public consultation, with a final report expected in the last quarter of the year.

Portfolio Pulse from Shivani Kumaresan

May 21, 2024 | 12:15 pm

TNXP

Tonix Pharmaceuticals announced key findings from EVERSANA's market opportunity analysis for Tonmya, a potential new non-opioid treatment for fibromyalgia. The analysis revealed high interest from primary physicians and dissatisfaction with current FDA-approved drugs. Tonix plans to submit a New Drug Application to the FDA in the second half of 2024.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 12:14 pm